Polar Capital Global Healthcare Trst : Top Ten Equity Holdings and Exposures

6^th June 2019

Polar Capital Global Healthcare Trust plc (the 'Company')

Top Ten Equity Holdings and Sector and Geographic Exposure as at 31^st May 2019 and full Portfolio listing as at 30^th April 2019 available from company's website

Polar Capital Global Healthcare Trust plc is pleased to announce that as at 31^st May 2019 the top ten equity holdings and the sector and geographic breakdown were as follows:

Top 10 Holdings	%
Merck & Co	5.8%
Pfizer	5.6%
Abbott Laboratories	5.6%
Roche	4.4%
Alexion Pharmaceuticals	4.3%
Takeda Pharmaceutical	4.2%
Novartis	4.1%
HCA Holdings	3.8%
AstraZeneca	3.7%
Koninklijke Philips	3.7%
Total	45.2%

Sector Exposure	%
Healthcare Equipment	38.0%
Pharmaceuticals	30.6%
Biotechnology	15.0%
Life Sciences Tools & Services	9.1%
Healthcare Facilities	4.1%
Healthcare Services	3.3%
Managed Healthcare	3.0%
Healthcare Supplies	2.1%
Healthcare Technology	0.5%
Education Services	0.3%
Healthcare Distributors	0.3%
Cash	-6.4%
Total	100.0%

Geographic Exposure	%
United States	65.5%
United Kingdom	14.9%
Switzerland	8.5%
Japan	5.8%
Netherlands	3.7%
Ireland	3.5%
Spain	3.0%
Denmark	0.6%
Italy	0.6%
France	0.3%
Sweden	0.1%
Cash	-6.4%
Total	100.0%

Gearing Ratio as calculated in accordance with the guidelines of the Association of Investment Companies, was 6.9%. Gearing is made up of structural debt provided by the subsidiary company PCGH ZDP plc, through the issue of zero dividend preference shares.

The monthly factsheet will usually be available on the Company's website on the 10^th working day after the month end and includes a commentary by the investment manager. www.Polarcapitalhealthcaretrust.co.uk

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.